Sarepta's stock price plummets after an 'erroneous' report - STAT

Sarepta's stock price plummets after an 'erroneous' report - STAT

Sarepta’s stock price plummets after an ‘erroneous’ report

By KATE SHERIDAN

KRISTOFFER TRIPPLAAR/SIPA USA)(SIPA VIA AP

Shares plummeted after an analyst discovered that a patient in one of the company’s trials for Duchenne muscular dystrophy reported a serious side effect.

READ MORE